tirzepatide for cardiovascular disease outcomes of semaglutide and patients with type 2 diabetes in clinical practice Tirzepatide and Cardiovascular Health: Protect

Finally, it is critical that communities of patients with long COVID and associated conditions are meaningfully engaged in long COVID research and clinical trials

Amazing results

If you are looking for more information on the latest studies, consider reading through our other blogs here!

MotherToBaby Fact Sheets summarize all the available scientific information to determine whether or not parents and their developing babies are at risk because of an exposure

Tirzepatide doses (2.5 mg to 15 mg) are numerically higher than semaglutide doses (0.25 mg to 2.4 mg), but this doesnt mean tirzepatide is stronger milligram for milligram

So I decided to try tirzepatide